CXAI
CXAppCAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
This remains a cautious monitoring setup rather than a strong directional thesis. Primary sources show a business with improving revenue mix but shrinking top line, persistent losses, and material financing/listing overhang: the 2025 10-K reported $4.583 million of revenue, $13.473 million of net loss, $10.381 million of operating cash burn, and explicit substantial-doubt language that management says it can mitigate, while the April 10, 2026 8-K disclosed another 4.1 million shares issued to Avondale [#10-K-2026-03-30] [#8-K-2026-04-10]. Deterministic signals are only neutral and catalyst density is low, so the most defensible stance is to treat CXAI as a fragile micro-cap where financing mechanics and Nasdaq compliance matter more than unproven growth narratives.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The April 10, 2026 8-K disclosed 4,116,659 common shares issued to Avondale across March 30, April 1, April 8, and April 10, 2026 at $0.180453, $0.18045, and $0.154427 per share, reinforcing near-term supply and financing overhang risk [#8-K-2026-04-10].
The 2026-03-30 10-K says CXAI failed to regain compliance by March 10, 2026 and received an extension until September 7, 2026 to meet Nasdaq's $1.00 minimum bid requirement, leaving a reverse-split or delisting decision window as a major event risk [#10-K-2026-03-30].
The 2025 10-K showed revenue fell to $4.583 million from $7.142 million, but gross margin improved to 87.4% as subscription revenue reached 98% of total revenue; a sustained proof point that this mix shift can slow operating cash burn would be the main constructive longer-duration setup, though evidence is still limited [#10-K-2026-03-30].
Recommendation
No formal recommendation provided.

